Braidwell LP
86 holdingsFiling period: 2026-06-30Current AUM: $2.91Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences Inc | 8.26M | $147.1M | $256.8M | 8.83% | +246.6K | 2026-06-30 |
| 2 | HNGE | Hinge Health Inc | 1.33M | $110.4M | $143.0M | 4.92% | -124,996 | 2026-06-30 |
| 3 | GKOS | Glaukos Corp | 591.9K | $82.7M | $102.7M | 3.53% | -171,578 | 2026-06-30 |
| 4 | EWTX | Edgewise Therapeutics Inc | 2.00M | $81.1M | $79.4M | 2.73% | -350,618 | 2026-06-30 |
| 5 | SYRE | Spyre Therapeutics Inc | 879.5K | $78.1M | $80.4M | 2.76% | -53,356 | 2026-06-30 |
| 6 | IRTC | Irhythm Holdings Inc | 654.3K | $77.8M | $74.5M | 2.56% | +44.1K | 2026-06-30 |
| 7 | NEO | Neogenomics Inc | 4.92M | $71.8M | $81.7M | 2.81% | -699,200 | 2026-06-30 |
| 8 | KOD | Kodiak Sciences Inc | 1.79M | $69.6M | $166.2M | 5.71% | -31,347 | 2026-06-30 |
| 9 | XENE | Xenon Pharmaceuticals Inc | 1.13M | $68.3M | $41.0M | 1.41% | -207,000 | 2026-06-30 |
| 10 | ATEC | Alphatec Hldgs Inc | 69.12M | $66.2M | $83.1M | 2.86% | +7.50M | 2026-06-30 |
| 11 | GLUE | Monte Rosa Therapeutics Inc | 2.45M | $59.3M | $27.8M | 0.96% | -755,012 | 2026-06-30 |
| 12 | DNTH | Dianthus Therapeutics Inc | 594.6K | $58.0M | $46.8M | 1.61% | -304,802 | 2026-06-30 |
| 13 | NBIX | Neurocrine Biosciences Inc | 336.2K | $56.7M | $47.7M | 1.64% | -315,950 | 2026-06-30 |
| 14 | ATEC | Alphatec Hldgs Inc | 6.53M | $56.5M | $70.9M | 2.44% | +4.36M | 2026-06-30 |
| 15 | GENB | Generate Biomedicines Inc | 3.28M | $55.4M | $42.4M | 1.46% | -309,155 | 2026-06-30 |
| 16 | MRVI | Maravai Lifesciences Hldgs I | 8.70M | $54.3M | $62.7M | 2.15% | -1,537,243 | 2026-06-30 |
| 17 | KRYS | Krystal Biotech Inc | 129.0K | $47.9M | $42.0M | 1.44% | -53,450 | 2026-06-30 |
| 18 | HUM | Humana Inc | 114.5K | $45.5M | $48.9M | 1.68% | -- | 2026-06-30 |
| 19 | TMO | Thermo Fisher Scientific Inc | 89.4K | $44.8M | $61.4M | 2.11% | -3,520 | 2026-06-30 |
| 20 | KYMR | Kymera Therapeutics Inc | 378.2K | $43.4M | $42.9M | 1.48% | +40.6K | 2026-06-30 |
| 21 | RYTM | Rhythm Pharmaceuticals Inc | 381.1K | $42.3M | $34.4M | 1.18% | +70.5K | 2026-06-30 |
| 22 | DMRA | Damora Therapeutics Inc | 1.62M | $42.1M | $33.5M | 1.15% | +725.5K | 2026-06-30 |
| 23 | ACAD | Acadia Pharmaceuticals Inc | 1.65M | $41.7M | $33.7M | 1.16% | -824,800 | 2026-06-30 |
| 24 | BTSG | Brightspring Health Svcs Inc | 596.8K | $41.6M | $37.2M | 1.28% | -419,809 | 2026-06-30 |
| 25 | TMDX | Transmedics Group Inc | 609.7K | $40.5M | $45.6M | 1.57% | +280.3K | 2026-06-30 |
← Scroll →
Page 1 of 4